Kimia Biosciences Ltd.

KIMIABL

₹50.85

0.87% (0.44)

Market Cap

₹241 Cr.

P/E

25.03

Key Ratios

Edit Ratio's

Market cap

241 Cr

25.03

Prom Holding

74.94 %

ROE (%)

-1,603.84

ROCE (%)

-8.62

Div Yield (%)

Sales

110 Cr

OPM (%)

14.63 %

Debt to Equity

131

Edit Ratio's

About

Laurel Organics Ltd. is a Public limited company, was incorporated in September 1993 in distri… Read more

Low

52W Range

High

Timeline

Key company specific updates

Company Timeline

Custom financial statementNew

Edit rows

In Rs. Cr.	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025

In Rs. Cr.	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Balance sheet
Net Block	3.20	6.66	12.90	16.15	17.84	28.37	35.23	33.63	31.85	32.84
Shareholders Funds	-3.88	-4.61	2.29	6.11	13.37	18.44	14.89	5.46	0.33	9.97
Profit & Loss
Operating Profit	-3.38	-0.98	2.47	5.57	4.45	8.38	0.63	-5.09	-0.48	—
Net Sales	0.19	1.46	76.31	93.92	106	133	125	129	105	—
Cash flow
Cash from Operating Activity	-5.99	-0.74	-7.09	-2.65	0.31	5.97	8.00	-6.77	14.53	21.32
Net Capex (est)	0.10	6.23	2.75	2.56	8.97	13.51	1.51	2.81	1.51	4.60
Ratios
ROCE (%)	-102	-16.34	7.93	16.60	7.98	16.02	-2.94	-17.33	-8.62	—
ROE (%)	104	20.14	72.78	63.12	10.33	27.69	-24.87	-171	-1,604	—

Forensics

6 Yes

Positive for this company

2 Neutral

Neutral for this company

9 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days
Depreciation Effect

Company is depreciating a lower percentage of assets. this is contributing to an increase in net profit
Other Income

Other income component is making ratios of the company look optically better

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
Current vs Historic Valuation

Company is trading at a discount to 3yr historic valuations
Balance Sheet Strength

Balance sheet of the company is moderately strong
Debt

Company might have issues servicing its debt
ROE

Roe has decreased vs 10 year trend
Share price

Share price has increased over last 10 years but more due to rerating
Working Capital

Company has significant working capital which is dragging its roce and roe
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

R&D as a % of Total Sales (%)

Kimia Biosciences Ltd.

R&D as a % of Total Sales (%)
Source

Peer Comparison

Peer Name	Latest Price	PE	Market cap(Cr)	Prom Holding(%)	YoY Qtly Sales(%)	ROCE (%)	ROE (%)
Kimia Biosciences	50.85	25.03	241	74.94	15.12	-8.62	-1,603.84
Alpa Lab	99.8	10.74	209	57.29	69.1	13.64	11.04
Ambalal Sarabhai Ent	35.5	55.2	272	31.35	19.26	10.45	4.14
Coral Laboratories	590.65	8.74	211	71.51	-2.6	11.56	8.9
Balaxi Pharma.	49.95	11	276	65.99	27.46	21.1	-3.63
Murae Organisor	1.07	26.45	199	—	—	0.6	0.1
Gennex Lab	12.49	17.48	282	18.42	20.36	10.33	6.67
Krebs Biochem.&Inds	86.22	0.00	184	72.74	-49.05	-12.93	16.57

FAQs on Kimia Biosciences Ltd. Business

What does Kimia Biosciences do?

Laurel Organics Ltd. is a Public limited company specializing in the manufacturing of over thirty intermediates for various medical fields including Cardiovascular, Diabetes, and Dermatology.

Who are the competitors of Kimia Biosciences?

Kimia Biosciences major competitors are Coral Laboratories, Ambalal Sarabhai Ent, Alpa Lab, Balaxi Pharma., Murae Organisor, Gennex Lab, Krebs Biochem.&Inds.
Market Cap of Kimia Biosciences is ₹239 Crs.
While the median market cap of its peers are ₹209 Crs.

Is Kimia Biosciences financially stable compared to its competitors?

Kimia Biosciences seems to be less financially stable compared to its competitors.
Altman Z score of Kimia Biosciences is 2.27 and is ranked 7 out of its 8 competitors.

View FAQ's On Shareprice

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Kimia Biosciences Ltd.

Kimia Biosciences Ltd.

Key Ratios

About

Timeline

Company Timeline

6 Yes

2 Neutral

9 No

0 No Data

Accounting & Shareholding

Contingent Liabilities

Pledge

Retail Holding

Revenue Recognition

Promoter Holding

Depreciation Effect

Other Income

Price & Performance

Capex vs ROCE

Current vs Historic Valuation

Balance Sheet Strength

Debt

ROE

Share price

Working Capital

Sales Growth

Margin Stability

ROCE Strength

Product Wise Break-Up

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

R&D as a % of Total Sales (%)

What does Kimia Biosciences do?

Who are the competitors of Kimia Biosciences?

Is Kimia Biosciences financially stable compared to its competitors?

Kimia Biosciences Ltd.

Kimia Biosciences Ltd.

Key Ratios

About

Timeline

Company Timeline

6 Yes

2 Neutral

9 No

0 No Data

Accounting & Shareholding

Contingent Liabilities

Pledge

Retail Holding

Revenue Recognition

Promoter Holding

Depreciation Effect

Other Income

Price & Performance

Capex vs ROCE

Current vs Historic Valuation

Balance Sheet Strength

Debt

ROE

Share price

Working Capital

Sales Growth

Margin Stability

ROCE Strength

Product Wise Break-Up

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

R&D as a % of Total Sales (%)

R&D as a % of Total Sales (%)

What does Kimia Biosciences do?

Who are the competitors of Kimia Biosciences?

Is Kimia Biosciences financially stable compared to its competitors?

SIGN UP FOR FREE